Search

Search Results
Results 41 - 50 of 170 for parkinson
  • Solian
    Drug - 16 Feb 2023
    Consumer Medicine Information (CMI) about Solian intended for persons living in Australia.
  • Amisulpride Winthrop
    Drug - 16 Feb 2023
    Consumer Medicine Information (CMI) about Amisulpride Winthrop intended for persons living in Australia.
  • Rixadone Oral
    Drug - 9 Feb 2023
    Consumer Medicine Information (CMI) about Rixadone Oral (Risperidone Oral solution 1mg/mL) intended for persons living in Australia.
  • Micardis Plus
    Drug - 24 Jan 2023
    Consumer Medicine Information (CMI) about Micardis Plus (telmisartan and hydrochlorothiazide) intended for persons living in Australia.
  • Tetrabenazine
    Drug - 16 Nov 2022
    Consumer Medicine Information (CMI) about Tetrabenazine intended for persons living in Australia.
  • Amlodipine/Valsartan/HCT Novartis
    Drug - 2 Nov 2022
    Consumer Medicine Information (CMI) about Amlodipine/Valsartan/HCT Novartis (amlodipine besilate/valsartan/hydrochlorothiazide) intended for persons living in Australia.
  • Exforge HCT
    Drug - 1 Nov 2022
    Consumer Medicine Information (CMI) about Exforge HCT (amlodipine besilate/valsartan/hydrochlorothiazide) intended for persons living in Australia.
  • Co-Diovan
    Drug - 1 Nov 2022
    Consumer Medicine Information (CMI) about Co-Diovan (Valsartan/hydrochlorothiazide) intended for persons living in Australia.
  • Rixadone
    Drug - 8 Sep 2022
    Consumer Medicine Information (CMI) about Rixadone (risperidone) intended for persons living in Australia.
  • Avapro HCT
    Drug - 7 Sep 2022
    Consumer Medicine Information (CMI) about Avapro HCT intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback